FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2142346319> ?p ?o ?g. }

• W2142346319 endingPage "2725" @default.
• W2142346319 startingPage "2717" @default.
• W2142346319 abstract "Although human immunodeficiency virus (HIV) disease is increasing rapidly among women, no prior studies have investigated gender-based therapeutic strategies for the treatment of acquired immunodeficiency syndrome (AIDS) and its complications in this population. Markedly decreased serum androgen levels have been demonstrated in women with AIDS and may be a contributing factor to the wasting syndrome in this population. To assess the effects of androgen replacement therapy in women with AIDS wasting, we conducted a randomized, placebo-controlled, pilot study of transdermal testosterone administration. The primary aim of the study was to determine efficacy in terms of the change in serum testosterone levels, safety parameters and tolerability. A secondary aim of the study was to investigate testosterone effects on weight, body composition, quality of life, and functional indexes. Fifty-three ambulatory women with the AIDS wasting syndrome defined as weight less than 90% of ideal body weight or weight loss of more than 10% of the preillness maximum, free of new opportunistic infection within 6 weeks of study initiation, and with screening serum levels of free testosterone less than the mean of the normal reference range (< 3 pg/mL) were enrolled in the study. Subjects were age 37 +/- 1 yr old (mean +/- SEM), weighed 92 +/- 2% of ideal body weight, and had lost 17 +/- 1% of their maximum weight. CD4 count was 324 +/- 36 cells/mm3, and viral burden was 102,382 +/- 28,580 copies. Subjects were randomized into three treatment groups, in which two placebo patches (PP), one active/one placebo patch (AP group), or two active patches (AA group) were applied twice weekly to the abdomen for 12 weeks. The expected nominal delivery rates of testosterone were 150 and 300 microg/day, respectively, for the AP and AA groups. Forty-five subjects completed the study (PP group, n = 13; AP group, n = 14; AA group, n = 18). Two additional subjects from the PP group and two from the AP group were included in the intent to treat analysis. Serum free testosterone levels increased significantly from 1.2 +/- 0.2 to 5.9 +/- 0.8 pg/mL (AP) and from 1.9 +/- 0.4 to 12.4 +/- 1.6 pg/mL (AA) in response to testosterone administration (P < 0.0001 for comparison of AA vs. PP and AP vs. PP; normal range, 1.3-6.8 pg/mL). Testosterone administration was generally well tolerated locally and systemically, with no adverse trends in hirsutism scores, lipid profiles, or liver function tests. Weight increased significantly in the AP group (1.9 +/- 0.7 kg) vs. the PP group (0.6 +/- 0.8 kg; P = 0.043), but did not increase significantly in the AA group (0.9 +/- 0.4 kg; P = 0.263 vs. PP, by mixed effects model assessing the interaction of time and treatment on all available data, one-tailed test). Improved social functioning (P = 0.024, by one-tailed test) and a trend toward improved pain score (P = 0.059) were observed in the AP vs. the PP-treated patients (RAND 36-Item Health Survey questionnaire). Five of six previously amenorrheic patients in the AP group had spontaneous resumption of menses compared to only one of four amenorrheic patients in the AA group (P = 0.045 for comparison of actual number of periods during the study). This study is the first investigation of testosterone administration in women with AIDS wasting. We demonstrate a novel method to augment testosterone levels in such patients that is safe and well tolerated during short term administration. At the lower of the two doses administered in this study, testosterone therapy was associated with positive trends in weight gain and quality of life. Higher, more supraphysiological, dosing was not associated with positive trends in weight or overall well-being. These data suggest that testosterone administration may improve the status of women with AIDS wasting. Further studies are needed to assess the effects of testosterone on weight in HIV-infected women and to define the optimal therapeutic window for test" @default.
• W2142346319 created "2016-06-24" @default.
• W2142346319 creator A5000788602 @default.
• W2142346319 creator A5006163528 @default.
• W2142346319 creator A5019839561 @default.
• W2142346319 creator A5028892607 @default.
• W2142346319 creator A5041270273 @default.
• W2142346319 creator A5044481779 @default.
• W2142346319 creator A5052169338 @default.
• W2142346319 creator A5063043469 @default.
• W2142346319 creator A5072412701 @default.
• W2142346319 creator A5078384132 @default.
• W2142346319 creator A5087722659 @default.
• W2142346319 creator A5088481567 @default.
• W2142346319 creator A5089053900 @default.
• W2142346319 date "1998-08-01" @default.
• W2142346319 modified "2023-10-12" @default.
• W2142346319 title "Transdermal Testosterone Administration in Women with Acquired Immunodeficiency Syndrome Wasting: A Pilot Study1" @default.
• W2142346319 cites W1971230517 @default.
• W2142346319 cites W1974704788 @default.
• W2142346319 cites W1977057354 @default.
• W2142346319 cites W1984722913 @default.
• W2142346319 cites W1987348836 @default.
• W2142346319 cites W1992735212 @default.
• W2142346319 cites W1997238737 @default.
• W2142346319 cites W2011983694 @default.
• W2142346319 cites W2038281346 @default.
• W2142346319 cites W2038355611 @default.
• W2142346319 cites W2046428578 @default.
• W2142346319 cites W2049850715 @default.
• W2142346319 cites W2057103614 @default.
• W2142346319 cites W2064364551 @default.
• W2142346319 cites W2078387155 @default.
• W2142346319 cites W2129644831 @default.
• W2142346319 cites W2148688487 @default.
• W2142346319 cites W2150364761 @default.
• W2142346319 cites W2325363974 @default.
• W2142346319 cites W4240020485 @default.
• W2142346319 cites W4376999518 @default.
• W2142346319 doi "https://doi.org/10.1210/jcem.83.8.5051" @default.
• W2142346319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9709937" @default.
• W2142346319 hasPublicationYear "1998" @default.
• W2142346319 type Work @default.
• W2142346319 sameAs 2142346319 @default.
• W2142346319 citedByCount "54" @default.
• W2142346319 countsByYear W21423463192014 @default.
• W2142346319 countsByYear W21423463192016 @default.
• W2142346319 countsByYear W21423463192018 @default.
• W2142346319 countsByYear W21423463192020 @default.
• W2142346319 countsByYear W21423463192021 @default.
• W2142346319 crossrefType "journal-article" @default.
• W2142346319 hasAuthorship W2142346319A5000788602 @default.
• W2142346319 hasAuthorship W2142346319A5006163528 @default.
• W2142346319 hasAuthorship W2142346319A5019839561 @default.
• W2142346319 hasAuthorship W2142346319A5028892607 @default.
• W2142346319 hasAuthorship W2142346319A5041270273 @default.
• W2142346319 hasAuthorship W2142346319A5044481779 @default.
• W2142346319 hasAuthorship W2142346319A5052169338 @default.
• W2142346319 hasAuthorship W2142346319A5063043469 @default.
• W2142346319 hasAuthorship W2142346319A5072412701 @default.
• W2142346319 hasAuthorship W2142346319A5078384132 @default.
• W2142346319 hasAuthorship W2142346319A5087722659 @default.
• W2142346319 hasAuthorship W2142346319A5088481567 @default.
• W2142346319 hasAuthorship W2142346319A5089053900 @default.
• W2142346319 hasBestOaLocation W21423463191 @default.
• W2142346319 hasConcept C126322002 @default.
• W2142346319 hasConcept C134018914 @default.
• W2142346319 hasConcept C142724271 @default.
• W2142346319 hasConcept C197934379 @default.
• W2142346319 hasConcept C204787440 @default.
• W2142346319 hasConcept C27081682 @default.
• W2142346319 hasConcept C2777911890 @default.
• W2142346319 hasConcept C2778375690 @default.
• W2142346319 hasConcept C2779279991 @default.
• W2142346319 hasConcept C2779665388 @default.
• W2142346319 hasConcept C2779764123 @default.
• W2142346319 hasConcept C2908647359 @default.
• W2142346319 hasConcept C2911126609 @default.
• W2142346319 hasConcept C511355011 @default.
• W2142346319 hasConcept C544821477 @default.
• W2142346319 hasConcept C71315377 @default.
• W2142346319 hasConcept C71924100 @default.
• W2142346319 hasConcept C99454951 @default.
• W2142346319 hasConceptScore W2142346319C126322002 @default.
• W2142346319 hasConceptScore W2142346319C134018914 @default.
• W2142346319 hasConceptScore W2142346319C142724271 @default.
• W2142346319 hasConceptScore W2142346319C197934379 @default.
• W2142346319 hasConceptScore W2142346319C204787440 @default.
• W2142346319 hasConceptScore W2142346319C27081682 @default.
• W2142346319 hasConceptScore W2142346319C2777911890 @default.
• W2142346319 hasConceptScore W2142346319C2778375690 @default.
• W2142346319 hasConceptScore W2142346319C2779279991 @default.
• W2142346319 hasConceptScore W2142346319C2779665388 @default.
• W2142346319 hasConceptScore W2142346319C2779764123 @default.
• W2142346319 hasConceptScore W2142346319C2908647359 @default.
• W2142346319 hasConceptScore W2142346319C2911126609 @default.
• W2142346319 hasConceptScore W2142346319C511355011 @default.
• W2142346319 hasConceptScore W2142346319C544821477 @default.

• next